Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors

NCT02366312 is registered in ClinicalTrials.gov with NYU College of Dentistry as lead sponsor.

NCT NCT02366312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02366312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors
Lead sponsor
NYU College of Dentistry
Phase
Phase 2
Overall status
Completed
Start date
October 27, 2015
Completion date
August 31, 2019
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keratocystic odontogenic tumor